Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management Strategies for Duchenne Myopathy
NCT03633565Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Sep 2018
- Primary completion
- Sep 2021
- Modality
- Stem Cell Therapies, Small Molecules
01
Overview
A Phase 4 trial of ASP-001, mesenchymal stem cells in Duchenne muscular dystrophy (DMD), sponsored by Assiut University. Status: unknown.
02
Drugs
ASP-001mesenchymal stem cells
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT03633565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03633565.